To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Controlled Substances Market

Controlled Substances Market By Drug Class (Opioids, Stimulants, Depressants, Marijuana), By Application ( ADHD, Pain Management, Depression, Seizures, Anxiety, Others), By Distribution Channel (Institutional Sales, Retail Sales), and by Region - Global Market Insights 2023 to 2033

Analysis of Controlled Substances Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market, By Region

    3.2. Key Promotional Strategies, By Manufacturers

4. Key Success Factors

    4.1. Regulatory Scenario

    4.2. Drug Abuse Epidemiology

    4.3. Drug Abuse Statistics, U.S.

    4.4. Drug Abuse Statistics, European Union

    4.5. Pipeline Assessment

    4.6. Medical Marijuana Patent Filings

    4.7. Marijuana Statistics

    4.8. Medical Marijuana Market Value Chain Analysis and Regulatory Scenario

5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018-2022

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Changing Government Policies

        6.1.3. Reference Pricing

        6.1.4. Healthy economic growth in Emerging Countries

        6.1.5. Rise In Global Annual Disposable Income Per Capita

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Increasing Prevalence of Chronic Diseases

        6.2.2. Legalization of Marijuana And Reach of CS to Unmet Regions

        6.2.3. Rising Abuse

        6.2.4. Extensive Network of Distribution Channels

        6.2.5. Production Volume for Raw Materials, Like Opium and Marijuana

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity

7. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Drug Class

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2018 - 2022

    7.3. Current Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2023 - 2033

        7.3.1. Opioids

            7.3.1.1. Codeine

            7.3.1.2. Morphine

            7.3.1.3. Fentanyl

            7.3.1.4. Meperidine

            7.3.1.5. Methadone

            7.3.1.6. Oxycodone

            7.3.1.7. Others

        7.3.2. Stimulants

            7.3.2.1. Amphetamine

            7.3.2.2. Methylphenidate

            7.3.2.3. Dextroamphetamine

            7.3.2.4. Methamphetamine

            7.3.2.5. Others

        7.3.3. Depressants

            7.3.3.1. Barbiturates

            7.3.3.2. Benzodiazepines

        7.3.4. Marijuana

            7.3.4.1. Medical Marijuana

            7.3.4.2. Recreational Marijuana

    7.4. Market Attractiveness Analysis By Drug Class

8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Application

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Application, 2018 - 2022

    8.3. Current Market Size (US$ Mn) Analysis and Forecast By Application, 2023 - 2033

        8.3.1. Attention-Deficit/Hyperactivity Disorder (ADHD)

        8.3.2. Pain Management

        8.3.3. Depression

        8.3.4. Seizure

        8.3.5. Anxiety

        8.3.6. Sleep Disorders

        8.3.7. Cough Suppression

        8.3.8. Others

    8.4. Market Attractiveness Analysis By Application

9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2018 - 2022

    9.3. Current Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023 - 2033

        9.3.1. Institutional Sale

            9.3.1.1. Hospitals

            9.3.1.2. Clinics

            9.3.1.3. Rehabilitation Centers

        9.3.2. Retail Sales

            9.3.2.1. Retail Pharmacies

            9.3.2.2. E- Commerce/Mail Order Pharmacies

    9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 - 2022

    10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 - 2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Middle East and Africa (MEA)

        10.3.5. East Asia

        10.3.6. South Asia

        10.3.7. Oceania

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2018-2022 and Forecast 2023-2033

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Drug Class

        11.3.3. By Application

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Drug Class

        11.4.3. By Application

        11.4.4. By Distribution Channel

    11.5. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2018-2022 and Forecast 2023-2033

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Rest of Latin America

        12.3.2. By Drug Class

        12.3.3. By Application

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug Class

        12.4.3. By Application

        12.4.4. By Distribution Channel

    12.5. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2018-2022 and Forecast 2023-2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Drug Class

        13.3.3. By Application

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug Class

        13.4.3. By Application

        13.4.4. By Distribution Channel

    13.5. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2018-2022 and Forecast 2023-2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Drug Class

        14.3.3. By Application

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Drug Class

        14.4.3. By Application

        14.4.4. By Distribution Channel

    14.5. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2018-2022 and Forecast 2023-2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Drug Class

        15.3.3. By Application

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug Class

        15.4.3. By Application

        15.4.4. By Distribution Channel

    15.5. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2018-2022 and Forecast 2023-2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023 - 2033

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Drug Class

        16.3.3. By Application

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug Class

        16.4.3. By Application

        16.4.4. By Distribution Channel

    16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Turkey

            17.3.1.3. Northern Africa

            17.3.1.4. South Africa

            17.3.1.5. Rest of Middle East and Africa

        17.3.2. By Drug Class

        17.3.3. By Application

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Drug Class

        17.4.3. By Application

        17.4.4. By Distribution Channel

    17.5. Drivers and Restraints - Impact Analysis

18. Emerging Countries Market Analysis 2018-2022 and Forecast 2023-2033

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. South Africa Market Analysis

        18.2.1. Introduction

        18.2.2. Market Value Proportion Analysis by Market Taxonomy

        18.2.3. Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.2.3.1. By Drug Class

            18.2.3.2. By Distribution Channel

            18.2.3.3. By Application

        18.2.4. South Africa Market- Competition Landscape

    18.3. India Market Analysis

        18.3.1. Introduction

        18.3.2. Market Value Proportion Analysis by Market Taxonomy

        18.3.3. Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.3.3.1. By Drug Class

            18.3.3.2. By Distribution Channel

            18.3.3.3. By Application

        18.3.4. India Market- Competition Landscape

    18.4. Brazil Market Analysis

        18.4.1. Introduction

        18.4.2. Market Value Proportion Analysis by Market Taxonomy

        18.4.3. Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            18.4.3.1. By Drug Class

            18.4.3.2. By Distribution Channel

            18.4.3.3. By Application

        18.4.4. Brazil Market- Competition Landscape

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Deep Dive

        19.2.1. Cambrex

            19.2.1.1. Overview

            19.2.1.2. Product Portfolio

            19.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.1.4. Strategy Overview

        19.2.2. Cambrex

            19.2.2.1. Overview

            19.2.2.2. Product Portfolio

            19.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.2.4. Strategy Overview

        19.2.3. Patheon

            19.2.3.1. Overview

            19.2.3.2. Product Portfolio

            19.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.3.4. Strategy Overview

        19.2.4. Consort Medical

            19.2.4.1. Overview

            19.2.4.2. Product Portfolio

            19.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.4.4. Strategy Overview

        19.2.5. Cayman Chemical

            19.2.5.1. Overview

            19.2.5.2. Product Portfolio

            19.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.5.4. Strategy Overview

        19.2.6. AMRI

            19.2.6.1. Overview

            19.2.6.2. Product Portfolio

            19.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.6.4. Strategy Overview

        19.2.7. Siegfried AG

            19.2.7.1. Overview

            19.2.7.2. Product Portfolio

            19.2.7.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.7.4. Strategy Overview

        19.2.8. Johnson Matthey

            19.2.8.1. Overview

            19.2.8.2. Product Portfolio

            19.2.8.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.8.4. Strategy Overview

        19.2.9. SAFC/Cerilliant

            19.2.9.1. Overview

            19.2.9.2. Product Portfolio

            19.2.9.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.9.4. Strategy Overview

        19.2.10. Noramco, Inc

            19.2.10.1. Overview

            19.2.10.2. Product Portfolio

            19.2.10.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.10.4. Strategy Overview

        19.2.11. Mallinckrodt plc

            19.2.11.1. Overview

            19.2.11.2. Product Portfolio

            19.2.11.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.11.4. Strategy Overview

        19.2.12. GlaxoSmithKline plc.

            19.2.12.1. Overview

            19.2.12.2. Product Portfolio

            19.2.12.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.12.4. Strategy Overview

        19.2.13. Purdue Pharma L.P.

            19.2.13.1. Overview

            19.2.13.2. Product Portfolio

            19.2.13.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.13.4. Strategy Overview

        19.2.14. Teva Pharmaceuticals, Inc.

            19.2.14.1. Overview

            19.2.14.2. Product Portfolio

            19.2.14.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.14.4. Strategy Overview

        19.2.15. Johnson & Johnson (Janssen)

            19.2.15.1. Overview

            19.2.15.2. Product Portfolio

            19.2.15.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.15.4. Strategy Overview

        19.2.16. Daiichi Sankyo Company

            19.2.16.1. Overview

            19.2.16.2. Product Portfolio

            19.2.16.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.16.4. Strategy Overview

        19.2.17. Akorn Inc

            19.2.17.1. Overview

            19.2.17.2. Product Portfolio

            19.2.17.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.17.4. Strategy Overview

        19.2.18. Pfizer Inc.

            19.2.18.1. Overview

            19.2.18.2. Product Portfolio

            19.2.18.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.18.4. Strategy Overview

        19.2.19. Takeda Pharmaceutical Company Limited

            19.2.19.1. Overview

            19.2.19.2. Product Portfolio

            19.2.19.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.19.4. Strategy Overview

        19.2.20. Mylan N.V.

            19.2.20.1. Overview

            19.2.20.2. Product Portfolio

            19.2.20.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.20.4. Strategy Overview

        19.2.21. Sun Pharmaceutical Industries Ltd

            19.2.21.1. Overview

            19.2.21.2. Product Portfolio

            19.2.21.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.21.4. Strategy Overview

        19.2.22. Tilray

            19.2.22.1. Overview

            19.2.22.2. Product Portfolio

            19.2.22.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.22.4. Strategy Overview

        19.2.23. GW PHARMACEUTICALS PLC

            19.2.23.1. Overview

            19.2.23.2. Product Portfolio

            19.2.23.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.23.4. Strategy Overview

        19.2.24. Aphria Incorporation

            19.2.24.1. Overview

            19.2.24.2. Product Portfolio

            19.2.24.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.24.4. Strategy Overview

        19.2.25. Aurora Cannabis Inc

            19.2.25.1. Overview

            19.2.25.2. Product Portfolio

            19.2.25.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.25.4. Strategy Overview

        19.2.26. Canopy Growth Corporation

            19.2.26.1. Overview

            19.2.26.2. Product Portfolio

            19.2.26.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.26.4. Strategy Overview

        19.2.27. Insys Therapeutics, Inc.

            19.2.27.1. Overview

            19.2.27.2. Product Portfolio

            19.2.27.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.27.4. Strategy Overview

        19.2.28. Medical Marijuana, Inc.

            19.2.28.1. Overview

            19.2.28.2. Product Portfolio

            19.2.28.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.28.4. Strategy Overview

        19.2.29. The Peace Naturals Project

            19.2.29.1. Overview

            19.2.29.2. Product Portfolio

            19.2.29.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.29.4. Strategy Overview

        19.2.30. CANNABIS SATIVA, INC.

            19.2.30.1. Overview

            19.2.30.2. Product Portfolio

            19.2.30.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.30.4. Strategy Overview

        19.2.31. Green Relief Inc.

            19.2.31.1. Overview

            19.2.31.2. Product Portfolio

            19.2.31.3. Profitability by Market Segments (Product/Channel/Region)

            19.2.31.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Pipeline Assessment for Stimulants

Table 02: Expenditure on Health, (% of GDP), by Country, 2018–2022

Table 03: Expenditure on Health, (% of GDP), by Country, 2018–2022

Table 04: Global Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 05: Global Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 06: Global Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 07: Global Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 08: Global Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 By Region

Table 09: North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 10: North America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 11: North America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 12: North America Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 13: North America Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 14: Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 15: Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 16: Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 17: Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 18: Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 19: Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 20: Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 21: Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 22: Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 23: Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 24: East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 25: East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 26: East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 27: East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 28: East Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 29: South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 30: South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 31: South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 32: South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 33: South Asia Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 34: Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 35: Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 36: Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 37: Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 38: Oceania Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 39: MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Country

Table 40: MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 41: MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 42: MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 43: MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 44: Emerging Market Value Proportion Analysis 2018-2022 and Forecast 2023-2033, By Country vs Global value

Table 45: India Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 46: India Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 47: India Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 48: India Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 49: South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 50: South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 51: South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 52: South Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Table 53: Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 54: Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

Table 55: Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Application

Table 56: Brazil Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Pipeline Assessment For Opioids, By phase

Figure 02: Pipeline Assessment For Opioids, By Trial Status

Figure 03: Pipeline Assessment For Stimulants, By phase

Figure 04: Pipeline Assessment For Stimulants, By Trial Status

Figure 05: Medical Marijuana Patent Citations Analysis, 2018–2022, By Country

Figure 06: Medical Marijuana Patent Citations Analysis, from 2023–2033

Figure 07: Global Market Value Analysis and Forecast, 2018–2033 (US$ Mn)

Figure 08: Global Market Absolute $ Opportunity (US$ Mn), 2018–2022

Figure 09: Global Market Absolute $ Opportunity (US$ Mn), 2018–2033

Figure 10: Global Market Share%, by Drug Class, 2022E - Opioids

Figure 11: Global Market Share%, by Drug Class, 2022E - Stimulants

Figure 12: Global Market Share%, by Drug Class, 2022E - Depressants

Figure 13: Global Market Share%, by Drug Class, 2022E - Marijuana

Figure 14: Global Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 15: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 16: Global Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 17: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 18: Global Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 19: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 20: Global Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 21: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 22: Global Market Attractiveness Analysis, By Drug Class

Figure 23: Global Market Attractiveness Analysis, By Application

Figure 24: Global Market Attractiveness Analysis, By Distribution Channel

Figure 25: Global Market Incremental Opportunity US$, by Region, 2018-2033

Figure 26: Market Share%, by Region, 2022E

Figure 27: Global Market Absolute Opportunity US$, by Region, 2023-2033

Figure 28: Market Share%, by Region, 2033F

Figure 29: Global Market Attractiveness Analysis, By Region

Figure 30: North America Market size (US$ Mn) Analysis, 2018–2022

Figure 31: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 32: US Market Size (US$ Mn) Analysis, 2018–2022

Figure 33: US Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 34: Canada Market Size (US$ Mn) Analysis, 2018–2022

Figure 35: Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 36: North America Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 37: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 38: North America Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 39: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 40: North America Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 41: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 42: North America Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 43: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 44: North America Market Attractiveness Analysis, By Drug Type

Figure 45: North America Market Attractiveness Analysis, By Application

Figure 46: North America Market Attractiveness Analysis, By Distribution Channel 

Figure 47: North America Market Attractiveness Analysis, By Country

Figure 48: Latin America Market size (US$ Mn) Analysis, 2018–2022

Figure 49: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 50: Brazil Market Size (US$ Mn) Analysis, 2018–2022

Figure 51: Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 52: Mexico Market Size (US$ Mn) Analysis, 2018–2022

Figure 53: Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 54: Rest of Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 55: Rest of Latin America Market Size (US$ Mn) Analysis, 2018–2022

Figure 56: Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 57: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 58: Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 59: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 60: Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 61: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 62: Latin America Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 63: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 64: Latin America Market Attractiveness Analysis, By Drug Type

Figure 65: Latin America Market Attractiveness Analysis, By Application

Figure 66: Latin America Market Attractiveness Analysis, By Distribution Channel 

Figure 67: Latin America Market Attractiveness Analysis, By Country

Figure 68: Europe Market size (US$ Mn) Analysis, 2018–2022

Figure 69: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 70: U.K. Market Size (US$ Mn) Analysis, 2018–2022

Figure 71: U.K. Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 72: Germany Market Size (US$ Mn) Analysis, 2018–2022

Figure 73: Germany Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 74: France Market Size (US$ Mn) Analysis, 2018–2022

Figure 75: France Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 76: Italy Market Size (US$ Mn) Analysis, 2018–2022

Figure 77: Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 78: Spain Market Size (US$ Mn) Analysis, 2018–2022

Figure 79: Spain Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 80: BENELUX Market Size (US$ Mn) Analysis, 2018–2022

Figure 81: BENELUX Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 82: Russia Market Size (US$ Mn) Analysis, 2018–2022

Figure 83: Russia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 84: Rest of Europe Market Size (US$ Mn) Analysis, 2018–2022

Figure 85: Rest of Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 86: Europe Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 87: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 88: Europe Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 89: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 90: Europe Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 91: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 92: Europe Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 93: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 94: Europe Market Attractiveness Analysis, By Drug Type

Figure 95: Europe Market Attractiveness Analysis, By Application

Figure 96: Europe Market Attractiveness Analysis, By Distribution Channel 

Figure 97: Europe Market Attractiveness Analysis, By Country

Figure 98: East Asia Market size (US$ Mn) Analysis, 2018–2022

Figure 99: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 100: China Market Size (US$ Mn) Analysis, 2018–2022

Figure 101: China Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 102: Japan Market Size (US$ Mn) Analysis, 2018–2022

Figure 103: Japan Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 104: South Korea Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 105: South Korea Market Size (US$ Mn) Analysis, 2018–2022

Figure 106: East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 107: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 108: East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 109: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 110: East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 111: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 112: East Asia Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 113: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 114: East Asia Market Attractiveness Analysis, By Drug Type

Figure 115: East Asia Market Attractiveness Analysis, By Application

Figure 116: East Asia Market Attractiveness Analysis, By Distribution Channel 

Figure 117: East Asia Market Attractiveness Analysis, By Country

Figure 118: South Asia Market size (US$ Mn) Analysis, 2018–2022

Figure 119: Global Donor Egg IVF Market Attractiveness Analysis by Region , 2023-2033

Figure 119: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 120: India Market Size (US$ Mn) Analysis, 2018–2022

Figure 121: India Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 122: Thailand Market Size (US$ Mn) Analysis, 2018–2022

Figure 123: Thailand Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 124: Indonesia Market Size (US$ Mn) Analysis, 2018–2022

Figure 125: Indonesia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 126: Malaysia Market Size (US$ Mn) Analysis, 2018–2022

Figure 127: Malaysia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 128: Rest of South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 129: Rest of South Asia Market Size (US$ Mn) Analysis, 2018–2022

Figure 130: South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 131: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 132: South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 133: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 134: South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 135: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 136: South Asia Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 137: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 138: South Asia Market Attractiveness Analysis, By Drug Type

Figure 139: South Asia Market Attractiveness Analysis, By Application

Figure 140: South Asia Market Attractiveness Analysis, By Distribution Channel 

Figure 141: South Asia Market Attractiveness Analysis, By Country

Figure 142: Oceania Market size (US$ Mn) Analysis, 2018–2022

Figure 143: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 144: Australia Market Size (US$ Mn) Analysis, 2018–2022

Figure 145: Australia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 146: New Zealand Market Size (US$ Mn) Analysis, 2018–2022

Figure 147: New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 148: Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 149: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 150: Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 151: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 152: Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 153: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 154: Oceania Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 155: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 156: Oceania Market Attractiveness Analysis, By Drug Type

Figure 157: Oceania Market Attractiveness Analysis, By Application

Figure 158: Oceania Market Attractiveness Analysis, By Distribution Channel 

Figure 159: Oceania Market Attractiveness Analysis, By Country

Figure 160: MEA Market size (US$ Mn) Analysis, 2018–2022

Figure 161: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 162: South Africa Market Size (US$ Mn) Analysis, 2018–2022

Figure 163: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 164: GCC Countries Market Size (US$ Mn) Analysis, 2018–2022

Figure 165: GCC Countries Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 166: Rest of MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 167: Rest of MEA Market Size (US$ Mn) Analysis, 2018–2022

Figure 168: MEA Market Size (US$ Mn) Analysis, 2018–2022, by Opioids

Figure 169: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Opioids

Figure 170: MEA Market Size (US$ Mn) Analysis, 2018–2022, by Stimulants

Figure 171: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Stimulants

Figure 172: MEA Market Size (US$ Mn) Analysis, 2018–2022, by Depressants

Figure 173: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Depressants

Figure 174: MEA Market Size (US$ Mn) Analysis, 2018–2022, by Marijuana

Figure 175: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033, by Marijuana

Figure 176: MEA Market Attractiveness Analysis, By Drug Type

Figure 177: MEA Market Attractiveness Analysis, By Application

Figure 178: MEA Market Attractiveness Analysis, By Distribution Channel 

Figure 179: MEA Market Attractiveness Analysis, By Country

Figure 180: Market Value Proportion Analysis, By Key Countries, 2022E

Figure 181: Global Vs. Country, Y-O-Y Growth Comparison

Figure 182: India Market size (US$ Mn) Analysis, 2018–2022

Figure 183: India Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 184: India Market Attractiveness Analysis, By Drug Class

Figure 185: India Market Attractiveness Analysis, By Application

Figure 186: India Market Attractiveness Analysis, By Distribution Channel

Figure 187: South Africa Market size (US$ Mn) Analysis, 2018–2022

Figure 188: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 189: South Africa Market Attractiveness Analysis, By Drug Class

Figure 190: South Africa Market Attractiveness Analysis, By Application

Figure 191: South Africa Market Attractiveness Analysis, By Distribution Channel

Figure 192: Brazil Market size (US$ Mn) Analysis, 2018–2022

Figure 193: Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2023–2033

Figure 194: Brazil Market Attractiveness Analysis, By Drug Class

Figure 195: Brazil Market Attractiveness Analysis, By Application

Figure 196: Brazil Market Attractiveness Analysis, By Distribution Channel

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Controlled Substances Market

Schedule a Call
Google translate